Detalhe da pesquisa
1.
Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement.
Br J Clin Pharmacol
; 87(12): 4658-4669, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33931884
2.
Pharmacokinetics, metabolism and safety of deuterated L-DOPA (SD-1077)/carbidopa compared to L-DOPA/carbidopa following single oral dose administration in healthy subjects.
Br J Clin Pharmacol
; 84(10): 2422-2432, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29959802
3.
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial.
Lancet Neurol
; 23(5): 477-486, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38631764
4.
Clinical pharmacokinetics of thalidomide.
Clin Pharmacokinet
; 43(5): 311-27, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15080764
5.
Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis.
Chest
; 122(1): 219-26, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12114362
6.
Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma.
J Exp Clin Cancer Res
; 32: 74, 2013 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-24422857
7.
A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment.
Cancer Chemother Pharmacol
; 66(2): 345-56, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19911123
8.
Effect of colesevelam on lovastatin pharmacokinetics.
Ann Pharmacother
; 36(3): 392-7, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11895049